In 2017, researchers in Leipzig timed how fast peptides broke down in serum (the fluid left after blood clots), plasma (blood’s fluid kept from clotting) and fresh mouse blood. Breakdown was faster in serum than plasma, and every peptide lasted longest in fresh blood. Even the stability ranking changed between conditions.
Same peptides, very different answers, depending only on the sample used. That is the in vitro vs in vivo difference in miniature: each research model asks a slightly different question, and gets its own answer.
Below: the main models, why results shift between them, and how to weigh each.
Quick answer: what is the difference between in vitro and in vivo studies?
In vitro studies test a substance outside a living organism, in cells or fluids in a dish. In vivo studies test it inside a living organism, usually an animal. In vitro work is controlled and suited to mechanisms; in vivo work shows what happens in a whole body. Neither alone predicts human outcomes.
In Vitro vs In Vivo: The Core Difference
In vitro is Latin for “in glass”: experiments in tubes, plates or flasks, using cells, enzymes or biological fluids. In vivo means “within the living”: experiments in whole organisms, which in research usually means animals.
In vitro work is good at isolating one thing at a time. Researchers can control concentration, timing and conditions, run many samples quickly and watch mechanisms directly. Its weakness is what a dish lacks: no circulation, no immune system, and no liver or kidneys clearing substances away.
In vivo work restores all of that. It shows how a substance behaves in a whole system: where it goes, how long it lasts and how organs interact. The cost is complexity. More variables sit outside the researcher’s control, studies are slower and more expensive, and results come from one species that may not match another.
Neither is simply better. They answer different questions, and strong evidence usually draws on both.
In Vitro vs In Vivo vs Ex Vivo
Between the dish and the living animal sits ex vivo work: tissue, blood or organs taken from an organism and studied outside it while still fresh. The Leipzig study is an example, with mouse blood studied for an hour outside the body.
Organoids push in vitro work closer to real tissue. They are small, three-dimensional structures grown from stem cells or patient tissue that reproduce some features of an organ.
Moving down the table adds realism and removes control.
Why In Vitro Results Don’t Always Translate In Vivo
A peptide stable in a dish can vanish quickly in a body, for three main reasons:
- Enzymes. Proteases, enzymes that cut peptides apart, vary by sample. The Leipzig authors warned that serum and plasma tests may highlight breakdown sites that matter less in vivo.
- Distribution. In an animal, a substance spreads into tissues.
- Clearance. The rate at which the body removes a substance, mainly via liver and kidneys.
A concrete example
Half-life is the time for half of a substance to be removed or broken down. In a pharmacokinetic study of BPC-157 in rats and dogs, the elimination half-life was under 30 minutes, and the peptide was rapidly broken into small fragments. A dish shows none of that, because nothing in it does the removing.
A review describes rapid in vivo breakdown as a general weakness of small peptides, and a critical review argues no published data show that in vitro clearance predicts whole-body clearance.
From Animals to Humans: The Second Gap
Translation means carrying findings from one model to the next. An umbrella review of animal-to-human translation found that about 5% of therapies tested in animals reached regulatory approval.
Species differ, and comparisons show it:
- A 2000 analysis, based on an industry survey of 12 drug companies, found rodent and non-rodent studies together flagged 71% of toxicities later seen in humans.
- A 2020 analysis of 108 drugs found toxicity in mice, rats, dogs and monkeys did not strongly predict toxicity in early human trials.
- A 2018 study comparing patient-derived organoids, organoid-based mouse models and patients concluded organoids can recapitulate patient responses.
Some researchers argue animal models predict human safety poorly and need rethinking. That is a viewpoint, not a consensus: the 2000 survey authors concluded animal studies predict many significant human toxicities.
For some well-known peptides, human data barely exist: a 2026 systematic review found three small human studies of BPC-157.
Peptide Purity in Cell-Based Assays
A cell-based assay measures how living cells in a dish respond to a substance. The cells sit in the test solution, so everything else in the vial reaches them too: related impurities, residual solvents and counter-ions.
A counter-ion is a peptide’s charged salt partner; TFA (trifluoroacetate) is common. In a 1999 in vitro study of rodent bone and cartilage cells, TFA at low concentrations reduced cell numbers in rat osteoblast cultures, with similar effects in chondrocytes and mouse skull tissue cultures. When TFA salts of several peptides were compared with hydrochloride salts, cell growth was consistently lower with TFA, enough to miss a real effect or report a false one.
What goes into the dish should be documented, not assumed. Purity, net peptide content and counter-ion all matter, as explained in What Does Peptide Purity Mean?. For an example of batch-level documentation, see the OHR COA page.
How to Weigh In Vitro and In Vivo Evidence
Each model contributes something, so the useful question is not which one to trust, but what each one can actually support. Ask:
- What model was used? Cells, organoid, ex vivo tissue, animal or human?
- Which species? Mouse, rat, dog and primate results may not match each other, let alone human results.
- What was measured? A mechanism in cells, a level in blood and an outcome in a whole animal are different claims.
- Has it been repeated? By another, independent lab, and in another model?
- Is there any human data? If so, how much, and of what quality?
- Was the material documented? Purity, net content and counter-ion matter most in cell work.
A finding that holds across several models, species and labs carries more weight than one striking result in one system. For a step-by-step guide to judging a study, see How to Read a Peptide Research Paper.
Frequently Asked Questions
What does ex vivo mean?
Ex vivo means “out of the living”: work on fresh tissue, blood or organs taken from an organism and studied outside it, such as mouse blood incubated for an hour. It sits between in vitro and in vivo, using real material without a whole body’s processes.
Is in vitro or in vivo more reliable?
Neither is more reliable in general; they answer different questions. In vitro studies are more controlled for mechanisms, while in vivo studies capture whole-body processes such as clearance. Reliability depends more on design, sample size and replication than on the model.
What is an organoid?
An organoid is a small, three-dimensional tissue structure grown in culture from stem cells or patient tissue. It mimics an organ more closely than flat cell cultures, but lacks blood flow, an immune system and the rest of a living body.
Why are animal studies used before human studies?
They show how a substance behaves in a whole living system: how it spreads, how long it lasts and which organs it affects. They remain an imperfect guide: in an umbrella review, about 5% of therapies tested in animals reached regulatory approval.
Closing
Each model answers a different question, and none tells the full story alone: the dish isolates, the animal integrates, and only human studies can speak to people. For consistent, documented materials across experiments, explore the OHR research catalogue.
Read Further: Preclinical vs Clinical Research: What’s the Difference?
This content is for informational and educational purposes only. Products referenced are intended for laboratory research use only and are not for human or animal consumption.




